ReviewRSC advances2025
A review of recent developments in rare earth-doped nanophosphors for emerging technological applications.
Review in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Rare-Earth Nanomaterials for Advanced Theranostics of Atherosclerosis.Chemical & biomedical imaging · 2026Review
- Different Alkali Carbonates on the Microstructure and Photoluminescence Properties of SrWOMolecules (Basel, Switzerland) · 2026Article
- A One-Step Ultrasonic Spray Pyrolysis Approach to Morphology-Controlled Synthesis of Hollow and Porous YBONanomaterials (Basel, Switzerland) · 2026Article
- Kinetically Encoded Microstrain Governs Growth, Electronic Structure, and Functionality in Microwave-Synthesized LuACS omega · 2026Article
- Lanthanide-Doped REVOSensors (Basel, Switzerland) · 2026Review
- Photoluminescence and thermoluminescence properties of ErRSC advances · 2026Article
- Judd-Ofelt analysis and the spectroscopic elucidation of β-BaBRSC advances · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This article explores the synthesis of rare-earth-doped nanophosphors (RENPs), focusing on selecting optimal host materials like tungstates, vanadates, and aluminates to enhance luminescent properties. The incorporation of rare-earth elements, such as Eu
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.